Halozyme Therapeutic (HALO)
58.06 x 3 64.00 x 1
Pre-market by (Cboe BZX)
60.57 +0.08 (+0.13%) 04/28/25 [NASDAQ]
58.06 x 3 64.00 x 1
Pre-market 61.01 +0.44 (+0.73%) 04:45 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 444,091 | 281,594 | 202,129 | 402,710 | 129,085 |
| Depreciation Amortization | 77,744 | 85,841 | 58,586 | 8,896 | 18,259 |
| Income taxes - deferred | 532 | 34,506 | 40,005 | -155,434 | N/A |
| Accounts receivable | -74,245 | -3,339 | -83,941 | 6,755 | -38,288 |
| Other Working Capital | -89,277 | -38,671 | -88,445 | 2,242 | -107,853 |
| Other Operating Activity | 120,219 | 28,640 | 111,776 | 34,271 | 54,251 |
| Operating Cash Flow | $479,064 | $388,571 | $240,110 | $299,440 | $55,454 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -252,027 | -81,615 | 490,919 | -404,832 | 79,782 |
| PPE Investments | -10,696 | -15,294 | 21,196 | -1,457 | -1,428 |
| Net Acquisitions | N/A | N/A | -999,120 | N/A | N/A |
| Investing Cash Flow | $-262,723 | $-96,909 | $-487,005 | $-406,289 | $78,354 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,072,000 | 784,875 | N/A |
| Debt Repayment | N/A | -13,483 | -516,573 | -369,064 | -19,560 |
| Common Stock Issued | 31,139 | 7,879 | 14,050 | 12,536 | 63,393 |
| Common Stock Repurchased | -250,000 | -402,383 | -200,002 | -350,058 | -150,117 |
| Other Financing Activity | 0 | 0 | -7,104 | -424 | 0 |
| Financing Cash Flow | $-218,861 | $-407,987 | $362,371 | $77,865 | $-106,284 |
| Beginning Cash Position | 118,370 | 234,695 | 119,219 | 148,203 | 120,679 |
| End Cash Position | 115,850 | 118,370 | 234,695 | 119,219 | 148,203 |
| Net Cash Flow | $-2,520 | $-116,325 | $115,476 | $-28,984 | $27,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | 479,064 | 388,571 | 240,110 | 299,440 | 55,454 |
| Capital Expenditure | -10,696 | -15,294 | -4,810 | -1,457 | -2,504 |
| Free Cash Flow | 468,368 | 373,277 | 235,300 | 297,983 | 52,950 |